Biomarkers for Prostate Cancer | GenomeWeb

The University of Michigan's Arul Chinnaiyan has led a study that identified several biomarkers for advanced stage prostate cancer, says an article at BBC. The researchers examined 1,126 molecules in a total of 262 samples of tissue, blood, or urine, and found one metabolite, sarcosine, to be a better predictor of late-stage disease than PSA. While a simple urine test is still around five years away, they say, it's promising work.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.